Vaccine Stability Testing & Shelf-Life Determination for mRNA Immunotherapy: Best Practices & Regulatory Insights
Learn about the critical importance of vaccine stability testing and shelf-life determination for mRNA immunotherapy. Discover key factors, degradation pathways, accelerated aging studies, and how to navigate regulatory challenges for mRNA vaccine approval. Come along with us as we untangle how Stability Testing and Shelf Strength Determination are done, revealing the best practices and clarifications, […]
Drug Product Salvaging: Ensuring Quality Standards After Exposure
Discover FDA’s Sec. 211.208 for salvaging drug products exposed to adverse conditions. Learn best practices to ensure quality, safety, and regulatory compliance. The pharmaceutical industry is the first line of defense against the health needs of the public. They supply various medicines to cure ailments that happen daily and worldwide, ensuring a better survival among […]
FDA Labeling Requirements for Medical Devices: Key Compliance Guidelines
Learn about FDA labeling requirements for medical devices. Ensure regulatory compliance with labeling integrity, traceability, and quality control for patient safety. Usage guidelines From implant that save lives to advanced diagnostic tool, medical devices are critical contributors in improving health and wellness of everyone.The sophisticated nature and diversity of these technologies lead to concerns surrounding […]
Validation Master Plan (VMP): Key to Regulatory Compliance
Learn about the importance of a Validation Master Plan (VMP) in ensuring regulatory compliance. Discover how VMP improves operational efficiency and minimizes risks. Here we reveal the secret weapon that quality and regulatory consulting firms utilize to make sure life science businesses meet and maintain regulatory compliance — The Validation Master Plan (VMP). What is […]
Avoiding Common Pitfalls in IND/IMPD Submissions: Key Tips
Discover common mistakes in IND/IMPD submissions and how to avoid them. Learn about preclinical data, clinical protocols, regulatory compliance, and more. We dissect these submissions to reveal common mistakes and how to avoid them. The Importance of IND/IMPD Submissions: Trusted Data: IND and IMPD applications require an integrative database of different types of evidence such […]
Conquer Your Next Audit: Top Tips for Regulatory Compliance Success
Prepare your organization for regulatory audits with these essential tips. Learn about compliance requirements, auditor prep, reporting, and more. Oversight by governing bodies to allow regular audits and inspections and comply with regulations offers the promise of further public trust. Although these assessments can seem daunting, preparation ensures they go off without a hitch. Below […]
Continuous Learning for Quality & Regulatory Professionals in Life Sciences
Explore the importance of continuous learning for quality and regulatory professionals in the life sciences industry. Learn how consulting firms can help maintain compliance. Life science industry is dynamic and constantly evolving, but quality and regulatory professionals are a key component in ensuring that the products and processes are safe, effective, and compliant. These professionals […]
Training Programs for Quality and Regulatory Professionals in Pharma & Biotech
Explore essential training programs for quality and regulatory professionals in pharma, biotech, and medical device industries. Learn about GMP, GCP, QMS, and more. Quality and regulatory professionals in the pharmaceutical, biotech and medical device arenas are essential to ensuring compliance with safety and efficacy. These fields are heavily regulated and professionals in these spaces need […]
FDA’s Approach to Drug Testing with Laboratory Animals and Ethical Considerations
Explore the FDA’s regulations for laboratory animal use in drug testing, ethical considerations, and the 3Rs principle for humane and effective drug development. The Role of Laboratory Animals in Drug Testing The FDA has implemented a broad set of regulations to ensure quality in drug manufacture and distribution in Chapter I of the 21 CFR […]
Challenges in Determining AI Limits for Nitrosamine Impurities in Pharmaceuticals
Explore the challenges in determining acceptable intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) in pharmaceutical safety assessments. Approaches and challenges for defining acceptable intake (AI) limits of nitrosamine drug substance-related impurities (NDSRIs). Defining allowable impurities is critical task for assuring patient safety in the complex world of pharmaceutical regulation. An example of thisy […]